Finding 588556 (2022-001)

-
Requirement
A
Questioned Costs
-
Year
2022
Accepted
2022-12-26
Audit: 16158
Auditor: Rsm US LLP

AI Summary

  • Core Issue: Lab expenses reported for Period 2 were overstated by about $1,059,000 due to double counting from two locations.
  • Impacted Requirements: Compliance with federal reporting criteria under CFR Part 200.303(a) and HRSA guidelines for accurate fund usage reporting.
  • Recommended Follow-Up: Management should enhance internal control processes to prevent future reporting errors.

Finding Text

Finding 2022-001? Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Reporting Federal program: Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution, ALN 93.498 Criteria: 2. CFR Part 200.303(a) states that the auditee must establish and maintain effective internal control over the federal awards that provides reasonable assurance that the auditee is managing the federal award in compliance with the federal statutes, regulations, and terms and conditions of the federal award. Specific criteria established by the Health Resources and Services Administration (HRSA) reporting guidance, establishes that providers who accept PRF payments agree to the Terms and Conditions of the Program, which include a requirement for providers to report on the use of funds. Providers who receive one or more payments totaling greater than $10,000 in the aggregate during a payment received period must report on use of funds in each applicable reporting period. Condition: Certain amounts reported as lab expenses for Period 2 were overstated by approximately $1,059,000. The Corporation double counted lab expenses from two locations. Cause: Upon review by management subsequent to Period 2 submission to the Reporting Portal, management identified an overstatement of certain lab expenses from two lab locations that were inadvertently included twice in the total eligible expenses within the Reporting Portal. Effect: Certain lab expenses reported for Period 2 in the Reporting Portal were overstated by approximately $1,059,000. Questioned costs: No Context: Lab expenses of approximately $1,059,000 out of total eligible expenses reported to the Reporting Portal for Period 2 of $10,400,983 were overstated. The error was isolated to the expenses from two outside labs reported in Period 2. Repeat finding? No Recommendation: We recommend management review and strengthen its internal control review process over reporting. Views of responsible officials of the auditee: The Corporation?s management agrees with the finding and the auditor?s recommendation.

Categories

Reporting Internal Control / Segregation of Duties

Other Findings in this Audit

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $24.06M
93.788 Opioid Str $456,915
93.461 Covid-19 Testing for the Uninsured $297,378
93.575 Child Care and Development Block Grant $238,140